MAGEA1 and neoplasm: In accordance with our results, a lower frequency of immunohistochemical-positive tumours compared to mRNA-positive tumours was recently reported in a study addressing GAGE, MAGE-A1 and NY-ESO-1 expression in oesophageal carcinomas (Akcakanat et al, 2005).